 |
Margaret M. Jastreboff, PhD, has been involved in tinnitus and decreased sound tolerance research since 1984, and on a full-time basis since 1991 while working at the University of Maryland School of Medicine. Her experimental work encompassed the study of the mechanisms of tinnitus using molecular biology, pharmacology, and behavioral techniques, including testing drugs for their effectiveness for tinnitus attenuation. She has been involved in clinical work for over 30 years while working first as an Associate Professor at Emory University, later as a Visiting Research Professor at Towson University and currently at JHDF, Inc collaborating closely with her husband Pawel J. Jastreboff, PhD. In 2001 she proposed a concept, name, and treatment for a specific version of decreased sound tolerance – misophonia – when patients exhibit negative reactions to specific for a given patient patterns of sound. After over 35 years in academia, where she was involved in basic science and clinical research, teaching AuD students, and treating patients, she became the President of JHDF, Inc., a non-profit foundation dedicated to research and education in the field of tinnitus and decreased sound tolerance as well as treating patients. In 1993 she shared with Dr. Pawel J. Jastreboff the Robert W. Hocks award for her contribution to the field of tinnitus. |
